PHAR 553.00: Therapeutics III by Rivey, Michael P. et al.
University of Montana 
ScholarWorks at University of Montana 
University of Montana Course Syllabi Open Educational Resources (OER) 
Fall 9-1-2008 
PHAR 553.00: Therapeutics III 
Michael P. Rivey 
University of Montana, Missoula, michael.rivey@umontana.edu 
Douglas Allington 
University of Montana, Missoula, douglas.allington@umontana.edu 
Rose Macklin 
University of Montana, Missoula, rose.macklin@umontana.edu 
Lee Ann Bradley 
University of Montana, Missoula 
Sarah Miller 
University of Montana, Missoula, sarah.miller@umontana.edu 
See next page for additional authors 
Follow this and additional works at: https://scholarworks.umt.edu/syllabi 
Let us know how access to this document benefits you. 
Recommended Citation 
Rivey, Michael P.; Allington, Douglas; Macklin, Rose; Bradley, Lee Ann; Miller, Sarah; Hudgins, Gayle A.; 
Beall, Donna G.; Madson, Kim; and Keeley, Kendra, "PHAR 553.00: Therapeutics III" (2008). University of 
Montana Course Syllabi. 11971. 
https://scholarworks.umt.edu/syllabi/11971 
This Syllabus is brought to you for free and open access by the Open Educational Resources (OER) at 
ScholarWorks at University of Montana. It has been accepted for inclusion in University of Montana Course Syllabi 
by an authorized administrator of ScholarWorks at University of Montana. For more information, please contact 
scholarworks@mso.umt.edu. 
Instructor 
Michael P. Rivey, Douglas Allington, Rose Macklin, Lee Ann Bradley, Sarah Miller, Gayle A. Hudgins, Donna 
G. Beall, Kim Madson, and Kendra Keeley 








































Pharmacy 553 Therapeutics III:  Fall 2008 
Lectures:   Tuesday & Thursday 9:10-11:00  SB 117 
Course Coordinator: Michael Rivey  ====>  M. Rivey 
Instructors:   Douglas Allington         Office:  243-6796 
   Rose Macklin      Community Hosp: 327-4299 
   Lee Ann Bradley                 ext. 7605 
   Sarah Miller               Pager: 329-6122 
   Gayle Hudgins   Home: 251-3369 
   Donna Beall    Cell: 546-5534 
   Kim Madson 
   Kendra Keeley 
    
 Material and Resources
 Required Texts: DiPiro Pharmacotherapy, 6th  edition 
APhA:  Handbook of Nonprescription Drugs 15th  edition 
Medical Letter on Drugs & Therapeutics 
Goodman & Gilman's Pharmacological Basis of Therapeutics 
A medical dictionary 
Pagana & Pagana: Diagnostic & Lab Test Ref., or other lab. text 
   
   
   
   
Optional Texts: Murphy: Clinical Pharmacokinetics pocket reference 
   Boh Pharmacy Practice Manual 
   Evans:  Applied Pharmacokinetics 
   Young, Koda-Kimble:  Applied Therapeutics 
   Herfindal, Gourley, Hart:  Clinical Pharmacy and Therapeutics 
   Hansten & Horn:  Drug Interactions 
         
 Goals of the Course
To promote the students' understanding of common disease 
states with particular emphasis on the facets of diseases 
that are amenable to drug therapy. 
To familiarize the student with the proper use of drugs in 
a clinical setting. 
 
To develop the students' awareness of factors that should be 
considered prior to selection of a drug and the appropriate 
parameters that should be monitored for therapeutic as well 
as undesired effects. 
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Performance Objectives
Upon completion of this course, each student shall be able to:
Relate the pathophysiology of a disease to the known or purported action of a drug.
Evaluate the seriousness of a disorder based on the signs and symptoms related to a
diagnosed problem, and:
--determine the necessity of drug therapy,
--when applicable, choose the proper drug and/or
drug product for the situation.
Determine the place of non-pharmacologic and natural therapies, when applicable.
Tailor the drug therapy of an individual based on patient characteristics and known 
pharmacokinetics principles.
Identify potential drug-drug interactions.
Monitor the appropriate parameters of a disease to determine if the patient is responding
positively to therapy.
Monitor for adverse drug reactions and exacerbations of underlying patient problems
resulting from drug therapy.
Student Responsibilities and Obligations
*To attend and participate in lecture sessions.
*To do assigned readings from the texts.
*To attend Integrated Studies conferences, prepare each case in advance, to present a 
patient case, and participate in the discussion of all patient presentations.




                         
                   
    
    






   
 
   
 


























GRADING IN COURSE:  Phar 553 Therapeutics III
3 midterm exams: 100 points each
Final exam (comprehensive, multiple choice)
(80 pts comprehensive, 50 pts over new topic lectures)
Topic quizzes:  8 quizzes graded on 10 pts each
TOTAL POINTS FOR COURSE
300 points
130 points
Bonus pts > 75% (60 pts)
430 POINTS
Class quizzes: The purposes of the quizzes are to promote reading of the text before a topic
and encourage class attendance and attention.  Quizzes will occur before topic lectures and will
test understanding of basic concepts in the reading assignment, and will cover only
chapter/reading material associated with the day the quiz is scheduled. If there are multiple 
chapters or readings, the one for quiz content is indicated.
A quiz will consist of 5 multiple choice or true/false questions, each worth 2 points. QUIZ on 
syllabus indicates a quiz will be given for assigned reading at start of the given lecture.  Lowest
2 quiz grades will be thrown out; no make-ups will be allowed for quiz. Scoring: Quiz
performance can only benefit student; bonus points for the course will be awarded for all
points over 75% (i.e. 60 pts) of the potential total 80 pts on the quizzes (10 total quizzes – 2 
throw-outs = 8x10 pts)
Exams: 
3 midterm exams:  Tests will be in "traditional" case report fashion with multiple choice/short
answers required.  Tests will be given on Thursday late afternoons 4:30-6:30 PM. 
Work is not an acceptable excuse for not taking a test during the test time.  Any excuse
for missing a test must be approved BEFORE the test is given, and an Agreement for
taking the test at an alternate time will be filed in the Dean’s Office.  Calculators may be 
required for tests; PDAs are not allowed.
Final exam:  65 multiple choice questions worth 2 pts each.  An effort will be made to design 
questions in the style similar to what you will encounter on the NAPLEX exam.
Grading: 
Grades generally follow closely to 90-100% A; 80-89% B; 70-79% C; 60-69% D, and below 60%
F.  Grades may be slightly given on a curve depending on overall students’ performance in 
course.  We do use the +/- system for grading
UM Statement 
All students must practice academic honesty.  Academic misconduct is subject to an academic
penalty by the course instructor and/or disciplinary sanction by the University
All students need to be familiar with the Student Conduct Code.  The Code is available for












    
   
   











    
  
    
   





    
    
 
      





Integrated Studies Conferences: you will be assigned to a conference based on period you 
registered for; instructors are not necessarily the ones under which you registered.
Attendance/make-up is required for all topics/cases; you may attend a different conference in 
order to complete the assignment, but ONLY with instructor permission.  The “make-up”
requirement for a conference missed due to unavoidable incident will be at the discretion of the
instructor, dependent on the topic.  Failure to complete any conference will result in a grade of
“fail” for course.
Class civility: Your student colleagues have strongly indicated to us that they wish to spend 
their valuable time in class listening to the therapeutics topics.  They do not appreciate any
“side” conversations while the instructor is lecturing.  They do appreciate students raising
questions about important lecture aspects for further discussion or clarification.
Out of respect for your classmates, we will not tolerate excessive and disruptive talking
during lecture.  The instructor may first ask you to be silent; you may be asked to leave class if
you persist in disruptive talking.  The instructor will be the judge of “what” constitutes
disruption. Please note that we encourage questions and relevant discussion.
Cell phones must be in the “off” mode during class.  Disruption due to the use of cell phones
in class will not be tolerated; this includes cell phones turned to the “vibration” mode.
Policy regarding young children: It may sometimes be necessary for a student to bring their
young child to class, due to school illness policy, daycare provider illness, or off-school days.  It
is acceptable to bring a child to class ONLY in those situations. Do not bring an acutely ill child 
to class. Please remember that children generally are NOT entertained by a therapeutics
lecture, so provide some activity for them during class.
It is the responsibility of the parent to assure that the child does not disrupt other students.
Reading assignments: Reading assignments as listed in the syllabus are for DiPiro 6th edition 
and the Handbook of Nonprescription Drugs 15th edition.
* NOTE: the DiPiro 6th edition was released in summer 2005. Material contained in a 
textbook typically is over 1 year old by the time the edition is printed. Please note that when
discrepancies arise between what the professor presents in lecture and what is contained in the
textbook, the content provided in class is more current- we strive to present the most current
information vs. what is contained in a textbook.
 
    
 
           
 
          
            
   
          
            
      
           
              
  
         
       
         
  
              
           
     
 
    
          
            
  
               
             
              
   
                     
            
          
  
           
         
     
 
         
           
               
       
            
 
     
        
           




Therapeutics 553 Pharm.D.: Lecture Syllabus
Instructor Reading
Aug 26 T Introduction/ Liver disease MPR 40
28 Th Liver disease MPR 37
Sept 2 Renal disease/ QUIZ DRA 41, 42
4 Renal Disease DRA 43, 44, pp 851-61
9 T Pain management/ QUIZ LAB 60
11 Th Headache DGB 59, OTC 5
16 T Contraception/ QUIZ DGB 77 (quiz), OTC 10
18 Th-1 Contraception DGB
18 Th-1 Urinary Disorders DRA 83, OTC 52
23 T Menopause/ QUIZ GAH 80
25 Th Osteoporosis GAH 88, OTC 459-460
25 Th Test 1 at 4:30-6:30 PM; through urinary disorders
30 T-1 no class, in lieu of test 1
30 T-2 Arthritis MPR 90, OTC 72-83
Oct 2 Th Arthritis/ QUIZ MPR 89 (quiz)
7 T-1 Gout MPR 91
7 T-2 Fluid & electrolytes SJM pp 937-50; 967-76
9 Th F & E SJM pp 950-63; 976-80
14 T Nutrition support/ QUIZ SJM pp 2559-64; 2569-72 ;
2591-8
16 Th Nutrition support SJM pp 2598-2611; 138
21 T Oncology/ QUIZ KAM TBA
23 Th Oncology KAM
23 Th Test 2 at 4:30-6:30 PM; through Nutrition Support
28T Oncology KAM
30 Th Nausea & Vomiting LAB 35, OTC 20
Nov 4 T ELECTION DAY: off (in lieu of test 2)
6 Th Asthma KAK 26
11 T VETERANS DAY: off (in lieu of test 3)
13 Th-1 Respiratory pharmacotherapy KAK 25, OTC 13
13 Th-2 COPD/ QUIZ DRA 27
553-Ther III, continued
 
           
 
            
           
          
             
       
 
              
     
 
  
              
       
          
 
  
    
 
    
  
 





Nov 18 T-1 COPD DRA
18 T-2 Thromboembolic disease/ QUIZ MPR 19
20 Th-1 TED MPR 
20 Th-2 Stroke MPR 20
20 Th Test 3 at 4:30-6:30 PM ; through COPD
25 M * Diabetes mellitus/ QUIZ LRM 72
27 Th OFF: THANKSGIVING HOLIDAY
Dec 2 T Diabetes mellitus LRM OTC 47
4 Th CLASS EVALUATION
Thyroid disease MPR 73
Final, Dec 10 at 1010-1200:  test 4, 130 pts comprehensive multiple choice
